ࡱ> lnks @ 0bjbjFF 0,,HHHHHHH\D D D 8| t \ 4  (@ @ @ @ @ @ 4666666$=RZiH@ @ @ @ @ ZHH@ @ @ XH@ H@ 4@ 4HH@ dwD N<0 OO\\HHHHOH @ @ @ @ @ @ @ ZZ\\$X\\ WHY SHOULD CHILD PSYCHIATRISTS BE INTERESTED IN RARE DISEASES? Olivier Bonnot, Raffaella Lucanto, David Cohen Rare diseases have a prevalence of nearly 2% in the general population (source  HYPERLINK "http://www.orphanet.org" www.orphanet.org). To be considered rare, an individual disease should have a prevalence of less than 1 in 2,000 people. Of note, most of these diseases affect only a few people, sometimes less than a dozen cases in France [in how many? 100,000? 1,000,000]. Caring for these patients is a major issue in the public health system. Patients almost always face the so called medical wandering, a term that describes the need for the patient to typically attend various centres and medical professionals as diagnosis and treatment typically require a multidisciplinary approach. Difficulties may increase when psychiatric symptoms, especially behavioural impairment, occur. Thus, medical practitioners who are qualified in their area of expertise may not be familiar with rare disease. Psychiatrists are not comfortable with heavy somatic pathology and paediatric and genetics professionals are equally uncomfortable with psychiatric symptoms. One answer to this health care issue has been provided by the French government with the 2004-2008 Rare Disease Program Certification. More than 250 medical units have been certified in various domains of rare disease, primarily genetic anomalies. Many rare diseases include nervous system tropism, with consequences for neurodevelopment and association with psychiatric symptoms. A majority of rare diseases are associated with mental retardation, which requires specific education and learning programs. Our topic in this short paper is not the unspecific psychological consequences for patients and their families when a severe disease is diagnosed. Rather, we are interested in instrumental impairments, learning disabilities, behavioural symptoms, and psychiatric diseases indirectly or directly associated with many rare genetic diseases. Three examples below illustrate why psychiatrists should be interested in rare disease. Tuberous sclerosis Tuberous sclerosis (TSC) is a heterogeneous genetic disorder with an estimated incidence rate of 1 in 8,000 to 1 in 30,000 births per year. Two genes are involved in approximately 50% of the reported cases: TSC1 (chromosome 9q34) and TSC2(chromosome 16p13). Beyond the classical somatic symptoms, mental retardation (MR) and seizures are frequent (40% and 60% of the patients, respectively). The severe (as opposed to mild) psychiatric phenotype typically includes severe MR, seizures, language disorders, and Kanner-type autism  ADDIN EN.CITE Cohen2005494917Cohen, D.Pichard, N.Tordjman, S.Baumann, C.Burglen, L.Excoffier, E.Lazar, G.Mazet, P.Pinquier, C.Verloes, A.Heron, D.Service de Psychiatrie de l'Enfant et de l'Adolescent, Groupe Hospitalier Pitie-Salpetriere, Paris. david.cohen@psl.ap-hop-paris.frSpecific genetic disorders and autism: clinical contribution towards their identificationJ Autism Dev DisordJ Autism Dev DisordJournal of autism and developmental disorders103-16351Autistic Disorder/diagnosis/epidemiology/*geneticsCausalityChildChromosome Aberrations/statistics & numerical dataComorbidityGenetic CounselingGenetic Diseases, Inborn/diagnosis/epidemiology/*geneticsGenetic Predisposition to Disease/geneticsHumansPhenotypeSyndrome2005Feb15796126http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15796126 [1]. Language abilities are impaired in the majority of individuals with TSC, although there is a wide range in the severity of this impairment. The mild phenotype of TSC is typically associated with normal early development, learning disabilities (e.g., dyscalculia), motor coordination impairments, attention deficit, and visual-spatial deficits  ADDIN EN.CITE de Vries20074417de Vries, P. J.Hunt, A.Bolton, P. F.Developmental Psychiatry Section, University of Cambridge, Douglas House, 18b Trumpington Road, Cambridge, CB2 2AH, UK. pd215@hermes.cam.ac.ukThe psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK familiesEur Child Adolesc PsychiatryEuropean child & adolescent psychiatryEur Child Adolesc PsychiatryEuropean child & adolescent psychiatryEur Child Adolesc PsychiatryEuropean child & adolescent psychiatry16-241612007Feb1018-8827 (Print)17268883http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17268883 internal-pdf://deVries 2007-1517930240/deVries 2007.pdfeng[2]. Although attention-deficit hyperactivity disorder (ADHD) is reported in more than 50% of individuals with TSC  ADDIN EN.CITE Gillberg1994373717Gillberg, I. C.Gillberg, C.Ahlsen, G.Department of Child and Adolescent Psychiatry, University of Goteborg, Sweden.Autistic behaviour and attention deficits in tuberous sclerosis: a population-based studyDev Med Child NeurolDevelopmental medicine and child neurologyDev Med Child NeurolDevelopmental medicine and child neurologyDev Med Child NeurolDevelopmental medicine and child neurology50-6361AdolescentAttention Deficit Disorder with Hyperactivity/diagnosis/*etiologyAutistic Disorder/*complications/diagnosisChildFemaleHumansIntelligence TestsMalePopulation SurveillancePrevalenceReproducibility of ResultsSweden/epidemiologyTuberous Sclerosis/*complications/epidemiology1994Jan0012-1622 (Print)8132114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8132114 engde Vries1999383817de Vries, PJBolton, PFNeuropsychychological attention deficits in children with tuberous sclerosis, abstractMolecular PsychiatryMolecular Psychiatrys514(Suppl)
s51
1999
[3, 4], attentional difficulties are frequently observed in individuals with TSC without a diagnosis of ADHD. However, few reports on neuropsychological profiles and psychiatric symptoms in TSC have been published. Increased knowledge in this field could be useful for patients and caregivers by providing a functional diagnosis. This functional diagnosis would include psychiatric, cognitive, language, logic, psychomotor, and visuospatial assessments, which are essential to helping and caring for patients. Catatonia Catatonia is a rare and severe psychiatric syndrome. In contrast to their adult counterparts, where bipolar disorder are the first diagnose, [what is the most common diagnosis in adults?], schizophrenia is the most frequently associated diagnosis in the child and adolescent population  ADDIN EN.CITE Lahutte2008541THESE 2007.enlEndNote54117<style face="normal" font="default" size="100%">Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making</style>[5]. Catatonia is often misdiagnosed when symptoms are not motor (echolaly, mutism, refusal to eat, acrocyanosis, verbigeration, social withdrawal...) [could you give a couple of examples of non-motor symptoms?]  ADDIN EN.CITE Bonnot2007452THESE 2007.enlEndNote45217<style face="normal" font="default" size="100%">Are Patients with Schizophrenia Insensitive to Pain? A Reconsideration of the Question</style>[6]. When encountered in a child and adolescent clinic, the syndrome must lead to specific investigations because it can be caused by a physical illness, usually a neurological, infectious, intoxication or genetic condition. Given that there is likely a bias in reporting organic cases, an estimation of the proportion of organic conditions in catatonic youth is 15-20%  ADDIN EN.CITE Lahutte2008541THESE 2007.enlEndNote54117<style face="normal" font="default" size="100%">Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making</style>[5]. The importance for clinical practice resides in the potential availability of an effective treatment for the underlying illness (e.g., plasmatic changes in catatonia associated with lupus erythematosus  ADDIN EN.CITE Perisse2003544THESE 2007.enlEndNote54417<style face="normal" font="default" size="100%">Case study: effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus and catatonia</style>[7], D-Penicillamine in Wilson disease). The syndrome is rare but severe and can potentially be lethal. The stakes are large not only for reducing psychiatric symptoms but also for changing the course of metabolic or neurological diseases. Apart from a thorough clinical history, systemic and neurologic examination, there are investigations that may assist clinicians in making a diagnosis. These are summarised in the Figure.  EMBED Diapositive Microsoft PowerPoint  Figure 1 Catatonia in children and adolescents: a multimodal framework for evaluation and treatment (PDD = pervasive developmental disorder; NLP = neuroleptic drug; SCZ = schizophrenia; ECT = electro-convulsive therapy) (from Lahutte et al., 2008) Cerebrotendinous xanthomatosis Cerebrotendinous Xanthomatosis (CTX) is an autosomal recessive disease of biliary acid synthesis. It is caused by mutations in the gene CYP27A1, localized in the long arm of chromosome 2 and coding for the mitochondrial enzyme sterol 27 hydroxylase. The metabolic block causes a progressive storage of cholesterol that is deposited in many tissues including the brain and tendons  ADDIN EN.CITE Moghadasian20023Xanthomatose Follow-up OB 5 oct 2008.enl</database><source-app name="EndNote" version="8.0">EndNote</source-app><rec-number>317<style face="normal" font="default" size="100%">Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations</style>[8]. CTX is associated with non-specific psychiatric symptoms and physical signs including tendinous xanthomas, cataract, diarrhea and neurological signs. Acute psychotic episodes have been described but most psychiatric symptoms occur during childhood or adolescence and are non-specific  ADDIN EN.CITE Berginer19882Xanthomatose Follow-up OB 5 oct 2008.enl</database><source-app name="EndNote" version="8.0">EndNote</source-app><rec-number>2</rec-number><ref-type name="Journal Article">17</ref-type><style face="normal" font="default" size="100%">Psychiatric disorders in patients with cerebrotendinous xanthomatosis</style>Estrov20006Xanthomatose Follow-up OB 5 oct 2008.enl</database><source-app name="EndNote" version="8.0">EndNote</source-app>617<style face="normal" font="default" size="100%">Psychiatric symptoms of inherited metabolic disease</style>[9, 10]. Given the cumulative effect of cholesterol accumulation, the course of symptoms parallels diagnostic delay. As an example, we describe two siblings with an early psychiatric presentation of CTX with ADHD and oppositional defiant disorder (ODD) followed by regression to mild intellectual disability and major behavioral impairments. In both cases, treatment with chenodeoxycholic acid improved externalizing symptoms and led to the partial recovery of cognitive impairments. The reported cases suggest that the presence of gradual cognitive deterioration after normal early development, learning disability, externalizing disorder and diarrhea in children should lead to the investigation of metabolic disorder. Knowledge of specific signs and symptoms of treatable neurometabolic diseases is crucial. The French government has certified one center for psychiatric symptoms in rare disease. In all the other centers (250) there are few psychiatrists or psychologists. However, functional diagnoses, in addition to the etiological diagnosis, could be useful for patients. The above examples show (i) the importance of a functional diagnoses in guiding professionals in caring for these patients and planning an integrative treatment; (ii) the need that professionals be aware that psychiatric and cognitive signs are associated with rare diseases (sometimes treatable) and that improvement in psychiatric and cognitive symptoms (often the first symptoms observed) is greater when diagnosed and treated early; and (iii) the importance of knowing about severe forms of psychiatric disease, such as catatonia, that have specific symptomatic treatments (e.g., lorazepam) and a high prevalence of comorbid organic conditions (up to 20%). References  ADDIN EN.REFLIST 1. Cohen D, Pichard N, Tordjman S et al. Specific genetic disorders and autism: clinical contribution towards their identification. Journal of Autism and Developmental Disorders 2005;35:103-116. 2. de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. European Child & Adolescent Psychiatry 2007;16:16-24. 3. Gillberg IC, Gillberg C, Ahlsen G. Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Developmental Medicine and Child Neurology 1994;36:50-56. 4. de Vries P, Bolton P. Neuropsychychological attention deficits in children with tuberous sclerosis, abstract. Molecular Psychiatry 1999;4:s51. 5. Lahutte B, Cornic F, Bonnot O et al. Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making. Progress in Neuropsychopharmacology and Biological Psychiatry 2008;32:1393-1398. 6. Bonnot O, Anderson GM, Cohen D et al. Are patients with schizophrenia insensitive to pain? A reconsideration of the question. Clinical Journal of Pain 2009; 25(3):244-52. 7. Perisse D, Amoura Z, Cohen D et al. Case study: effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus and catatonia. Journal of the American Acadamy of Child and Adolescent Psychiatry 2003;42:497-499. 8. Moghadasian MH, Salen G, Frohlich JJ et al. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Archives of Neurology 2002;59:527-529.  =?@opqvw ! " H T U V Y ` i j ̿vghQDh*0JCJmH sH 'jhQDh*CJUmH sH !jhQDh*CJUmH sH h*CJmH sH hQDh*CJmH sH hih*CJmH sH h|Qh*CJmH sH ho6h*CJmH sH hnh*CJmH sH hQDh*5CJmH sH h*5CJmH sH (@op=>QU-`-___````)*͓$dh`a$gd* dh]gd*gd*@&gd*dgd*dhgd* $dha$gd*dhgd*l j   * 4 < J M N O ] n  9 A J ] _  6 9 E H P _ d z # $ n w ʼhDgh*CJmH sH h*B*CJmH phsH !h|Qh*B*CJmH phsH  *hd\h*CJmH sH h*CJmH sH hQDh*CJmH sH E -TU\dn$-(*<=>Qcj[_+-KLde$jhQDh*5CJUmH sH hQDh*5CJmH sH h*5CJmH sH hDgh*5CJmH sH hDgh*CJmH sH hDgh*CJmH sH h*CJmH sH hQDh*CJmH sH :efk$79:S[io !! ! !!!G!J!|!}!~!!T+U+[+\+v+++++++",),-,6,~,,,,,,,,,---7-:-B-϶h*5CJmH sH hQDh*5CJmH sH $jhQDh*5CJUmH sH h*5CJPJmH sH hQDh*5CJPJmH sH HB-E-F-J-U-^-_-`-k-----..*.+.?.B.V.W.Z.^.~....;;;;;;; < <˾ufZfufuZh*CJPJmH sH hh*CJPJmH sH %jhh*CJPJUmH sH !hDgh*B*CJmH phsH  *hd\h*CJmH sH hh*CJmH sH h*CJmH sH hDgh*CJmH sH hDgh*CJmH sH hDgh*5CJmH sH hQDh*5CJmH sH h*5CJmH sH # <`<a<<<<<<AAAABB$B,B\BcBdBBBBBBBB;C^N^_^m^n^z^^^^^^/_>_C_W___________Żzrfjh*U^J_Hjh*UjJ h*CJUVaJhh*mH sH jh*Uh*mH sH h*CJmH sH hh*CJmH sH h*CJmH sH hh*CJmH sH %jhh*CJPJUmH sH h*CJPJmH sH hh*CJPJmH sH %__$````````````ajakarasauawa̬̾tf[Mf@6@6@6h*CJmH sH hQDh*CJmH sH hG)h*CJ\mH sH h*CJ\mH sH hQDh*CJ\mH sH hQDh*5CJ\mH sH h*5CJ\mH sH hQDh*5CJmH sH hQDh*CJmH sH #hh*CJH*^J_HmH sH h*CJ^J_HmH sH  hh*CJ^J_HmH sH &hh*5CJ\^J_HmH sH hh*^J_HmH sH wabb$b&bWbXbYb^bqqqqqq!q"qqqqq#r$r%r*rsɍ͍CDSs$1pt}~ď͏܏ǻ֬ǻ֬hQDh*CJPJmH sH h*CJPJmH sH hh*CJPJmH sH %jhQDh*CJPJUmH sH h*CJmH sH hQDh*CJmH sH D*.@DKXΐϐАؐ5NSWegz{|~ؑޑ +HIU^dwגؒLMNʓ͓Γϓړhih*5CJmH sH hih*CJmH sH hQDh*CJmH sH h*CJmH sH hQDh*CJmH sH J͓Γϓړ>ЖjT456|gd* ^`gd*dhgd*dhgd*l ړۓܓ}~7{6:;ҖovݗAEGPVij")-47OQ{әۙʲh uh*PJ!h uh*B*PJmH phsH  *huh*PJmH sH h*PJmH sH hh*PJmH sH h*CJmH sH hQDh*CJmH sH !jhQDh*CJUmH sH <9. Berginer VM, Foster NL, Sadowsky M et al. Psychiatric disorders in patients with cerebrotendinous xanthomatosis. American Journal of Psychiatry 1988;145:354-357. 10. Estrov Y, Scaglia F, Bodamer OA. Psychiatric symptoms of inherited metabolic disease. Journal of Inherited Metabolic Disiases 2000;23:2-6. Olivier Bonnot MD, PhD, Raffaella Lucanto PsyD , David Cohen MD, PhD Centre for Rare Disease with Psychiatric Symptoms ( HYPERLINK "http://crepsymar.apahp.fr" http://crepsymar.aphp.fr); Department for Child and Adolescent Psychiatry, University Hospital Pitie Salpetriere/Assistance Publique-Hpitaux de Paris; 47 boulevard de lhpital, 75013 Paris, France. E-Mail  HYPERLINK "mailto:olivier.bonnot@psl.aphp.fr" olivier.bonnot@psl.aphp.fr     Article IACAPAP Journal, 2009.  PAGE 4/ NUMPAGES 4 %+v|~ !&3567EFM`aefhqt{|Ⱥviih|Qh*CJmH sH  *huh*6CJmH sH h*6CJmH sH hnh*6CJmH sH  *huh*6CJmH sH h*6CJmH sH h+h*6CJmH sH !jhQDh*CJUmH sH h+h*PJmH sH h*PJmH sH hh*PJmH sH U&׹عٹٺںۺpqwxyz{|ĵĨąĨzrnrnrnrnd^dSd^d^hi0JmHnHu h*0Jjh*0JUh*jh*Uhih*mHsHhih*0JCJmHsH'jP/hQDh*CJUmH sH hih*CJmHsHh|Qh*0JCJmH sH !jhQDh*CJUmH sH 'j.hQDh*CJUmH sH h|Qh*CJmH sH h*CJmH sH gd* hih*mHsHh* h*0Jh*0JmHnHujh*0JU.:p*|. A!n"M#$% DyK www.orphanet.orgyK 2http://www.orphanet.org/-Dd 9Bz  s *A??c"$`"-ד^PL,  @=,ד^PLx tE`4Ix] |TEҤN $t 019$pF%d!(E숨. +,Hq<uQt`u9qpq^W;0v~WU^}W}U",#<ۃ6#|j!lf34IihZ|v9A?J tkPCVg<C+1!|4wxC&C8N3ߟ9IK>Tᘒ ֮:A4Q (| 2wEA3#|GAhPm4q.b2TSށ5^pvmld=h# FۻMJOjߋFӤm&n(5>LtAlFFQH{;7LJ6=Ie3>L=L,5P^j"9Y_;1m|=eSч[谷P/w>{ӼP`\.) nwZ׷^8׽.,+GBz"'KHS#6RGrlvlIu/o<c3 |@k*'d!ē,E C0<x1b]Ѽϵ<Zrtz`gkŗNLvEėMXs)c޵4{sS1F\"#6u!3F+!oC>>Q+[aq|o wѴyQ9M|APoyM[y>4 iV/f 1c FH/dqE"]dՔk6]DgX}y:4pl,?ٸ8㵱c0|c|ǡmbp+ z2 >18ou5_5r9\4\: B'7F㏧־K>cOn,cc؞>x?wf#).uONFq)=w or*UƬԻMY{Ygz<0T}3=6G2b1ݱlC'; qU>tD߯eQרIofz ~ 4I4Ǡ'*QDK ~Yg3Ly(<ď|#:c Ϣ䂇 %ܦjlJW|ALf\ٶ# wC$:m\1(Q, 3"~|eS̆[!l 76GI 1VvD>c#)ƃ3DMVpTqG|Vؼ6]r@cA+P qc3UAv$gɔO`GJ@m<'Z/F}sWXr65ɛgJ.>0cPUcf^Z6rWy^xӡ : :Fъ]mST^c(9E&Nju_;.s2ʇCFy>lSH,% V`6le(C؍3LXO7i>,҈s>$PvBJ(DDklӳT[9ۣܽb,͏8 vAphW*{(?8]pXX?q7kgeFRCeZʡӴW''[089PZIb)vb)WP$_ JK6$pvBlewh Xc9b*v~Dwb Ae6f3D/Weqapy:uB#(R 5WQtͱr|t$q5gqE;+Z_\jՍtmjvdjXWH} a[s2%Fc.VqZQnRX6:D: ~PY#S!ʈGƷl rEFbMϲk#QZ.j7[+fQD-ahUcXrDBۖmKmˠhjk6,Ѧ5QOm<-}۶ъmk9E&ԀұmVR0m[Al u~$?6ضPNǗm[Zm ж5mPZٚc(vLv=\d_́S#K~pDk2g%TGmYX 'ggw sz_ŋ 9ߴl"ټ&a-ڰ mXA}mVKh.N]N&&eh 6X z.x>RU |UX}Ebz(ڪ3Gj2Fh2)ڪ,2&1ڨ_^[c2ewE[QVKؙK:k1LT|[Ub0mUڪتc`%hj5ڪ mU k3 [z@6!*̳8{=yf|d fh] oh`OaFQGwJ%)mSگwį*) ~UI_uI=jqk²PmRIX6_;;r\`%y.72z64M &e "_ ym oaV<ߢ  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abdefghijmprquvwxyz{|}~Root Entry F`8xo@ Data c?0WordDocument0ObjectPool@7p`8x_1258136256dO)@7ppOle CompObj{ObjInfo  !"#$%&( dO)!Diapositive Microsoft PowerPointMSPresentationPowerPoint.Slide.89q _(SECSECOh+'0 X`x  Diapositive 4oSECSECOCXNAME contentsPictures Current User)SummaryInformation( PowerPoint Document(t8(DocumentSummaryInformation8 1TableO3CMicrosoft PowerPointP@0n@odч@h0N՜.+,0    dAffichage l'cranSamsung Electronics8(#A ArialTimesModle par dfau(=`/ 0DArialyClT0lz[ 0dDTimesyClT0lz[ 0d@ .  @n?" dd@  @@`` 0* 0@ ʚ;ʚ;g4DdDdz[ 0ppp@ 80___PPT10 pp?  %O  =X  /  ` 33` Sf3f` 33g` f` www3PP` ZXdbmo` \ғ3y`Ӣ` 3f3ff` 3f3FKf` hk]wwwfܹ` ff>>\`Y{ff` R>&- {p_/̴>?" dd@,|?" dd@   " @ ` n?" dd@   @@``PR    @ ` ` p>> (    6dC  `} C ['Cliquez pour modifier le style du titre( (:  0C  ` C vCliquez pour modifier les styles du texte du masque Deuxime niveau Troisime niveau Quatrime niveau Cinquime niveau4 w  0C ^ ` C >*  0C ^  C @*  0tC ^ ` C @*H  0޽h ? 3380___PPT10.-Z˔# "Modle par dfaut& 0 0 6(     0y P   y R*     0y    y T*   d  c $ ?  y:  0y  0 y vCliquez pour modifier les styles du texte du masque Deuxime niveau Troisime niveau Quatrime niveau Cinquime niveau4 w  6y _P  y R*     6"y _  y T*   H  0޽h ? 3380___PPT10.ч@ *" (  -  0/y@ OHospitalize in a psychiatric setting Manage malignant catatonia when necessary NP  P 2  0X8y 1Diagnose catatonia with appropriate rating scales82  1   6>y'S  bDetermine associated psychiatric condition: Acute onset? Mood symptoms? Hallucinations? Delusion?  c*9 c   6Dy S  ZDetermine complete psychiatric history: PDD? Learning disability? Stressor? Family style?  [&5 [   64KyS  MAddress possible organic condition: Neurological? Metabolic? Toxic? Genetic?  N", N 2  0|Py E  bSelect appropriate treatment    0Tys 'f  =Related to associated psychiatric condition: e.g. NLP for SCZ >+ >    0Ry M  qSymptomatic e.g. Sedative drugs"       0t]y Y  HRelated to associated organic condition: e.g. Plasma exchanges for lupus I'" I    0by]  7ECT   <fyI $  ? IF RESISTANCE XB   0DԔ@ @ XB @ 0DԔ@gwXB  0DԔ@cFXB  0DԔ@@ @ XB  0DԔS m m XB  0DԔF m m XB @ 0DԔ -s XB  0DԔ  XB  0DԔS Zc XB @ 0DԔS SFc XB  0DԔm m RB  s *DԔ m m IXB  0DԔf =  <dmy xo %Monitor risk of malignant catatonia !8&0 $bP  H  0޽h ? 3380___PPT10.   0 @((  ^  S     y  c $sy  0  y  H  0޽h ? 3380___PPT10.-ZiirP %? '0tDiapositive 4 Polices utilisesModle de conceptionTitres des diapositivesOh+'0 $0 L X dpx8Why should psychiatrists be interested in rare diseasesCHU de Toulouse Normal.d"UOy Qhx /=X'dVc1ޏ؞~-F2w–|U!==gGB\~8'_]7ȖX_~&0/.[fm-rrXh.?MO6Al,~>~l,}b`;a .`q=DzGu+US-׶j!tmK'kUSm>s$~qD{1sq'~xbEs;o7 y gyëMVӧ"c=o8!5߽8fAK1k6]O Oi;7}R%<%Z&-OCSb@˥ naҮg(ߟ_C) 8PtQ G_rsL֖1?/ :h^+`2|m{CcrVN><(/ YVQY 3B%QQw 5ctOc$ztqe}Lwå4uKmn +Oc EE4߹Ъ[O2e(?Nfk"2ػ'.^5t>>>l#;7ُ}7@8.!קSWD-Ԣ~Kt=Rֽ2fi$:xxQDףOۄdwsI4֣xpgHgd~0̹K0\9hy}_r3Ҋ<1拼>qG-d y Kŏ';e)ї5Egp?=DW03D H~ xWygT~<@;9swg.cٽ3_lE#?(УwC^%T#v@2RMw]x"RX[R ųX֛DɆ~5kڻgE􇾭~ooKpʷۄuۧ=TX³/}(ߊ>7ܷctzqtuua.,Ƈ5{buaGN#]*Hyx(O>.|/|^׫^zm ^׫c.-VV,k4isܤʓ9Gw΃ = !4|`~2eJ_ rW|%_ٺr0a]Wjgq 3&!=VL̹) ؟xIsb߇xk67THQof>h9G؞Sp1G1vvFR@Iqykת2>j[0_zٲn*WLXQ>$5d/MVk^b(;ƥo`8l "1&'g|H+GzZ ? |:5iUX7B&<xNU{Z‰avR=xշ }_qO: .֌׳ Eo)db;`uQĪ$8VӺV{+buiD=XM ຋?l3*c5Ehq7<v5ԧ&L9~Ajp'&tU'>' "e} U^jV/s2jQQ{ry቙0}OޭU_i/tw2|>F Vv+b캽 otV9V?yb5{VyY,ajULu|[*c`7EGՌn~~:U ꣇$~ft~:R+gWWUa'g%TﯪiLtw)x};9a o.{A> cϾLVq'a_]}bYE+gν8̚Pp3Տ vD1F&T'<ٓ鄄xτa޲9Co]zVtE`49x] pT>&< GB!,$*(c`bluh;*>(8-tSh;>j[>LkE ݛdlV2s??~xZ<:AWGvA3Li\Esm*10 R."(1|i yd8Otb5AK֮ g?w{$*UE lF@]Xna|B܀7uȆ/R+Fd>ֹ[osPh'__Xlo2(wZnyl@ %_f_c "9QS LzQ;ˣ[jCcRqXju890>B†+`} !FKNn!S8@xμ*cKV̫M:/Bu`''Ī`fFذ+ ײ%l+ٰ|70 lUX63L6ΖjVM/_=V']3$ך5LnG1R2Ϥ\sZF3#σI)|i0|1OQ3=x aty5![0ls^ Zo-^~*í6^3[Z.=+[\|hk: &QW%jNNX+++Hzc  1.xi"kfhPpΦ8 L~璼H(\  S,o?c"vń0 Z3 ;P.IA2kl)䄆JI9N:_ÞpC7۬7,\{iyϗ>RᕜjDVJJ_K?|=0 !ĝ>%S~`?N~$K=ȿME8%؎ŸOH;V+r4U*CxS8L^LB[>KП&QIB%ӡ0N J1} 0qAl>BE-ճ\;;@3g ;9^N-•}&?y1l F2k[G>&6l) m1k}Дro޶,8韖m,J -m|*y[_~lL*}Ķ;mԿm<|W>_Y4cG@<}L=2qL68x%dQe[8pq>g<+|Mt\Q87I֪}JEYIWF(*J<**;R#28W48q+/ v#/ܿx-S|X#?5*;Wɮ9cB,= &yAڅGZh_9.Cz^TڧXj+f_qGj"owR)x+|dj'c8%^ȡtnY\>p9 )p:ˇeB9l>_GqmS_Xh}nmNq񳃐D+%꿃&x;ڍ{hK~+ XgL@;#: 2T 뫂+J/JSN8Y1#?n$삃wի[Z׮j[ѺVk YWY,%+Z[fY+on[sU*uA\.T\;'Y-ׯZv9$h3m[߲-Aq͚%[ez_k^g y:ؾH ~ӫT+L^Փ'AxR̖e+VLyYݲfmG Y] yy=!ޒNQ81^I+SCScg7/L.Fϩ=vvp]> IWS vWߏ$Q:3W[gg coE|B\- 4KAf3Ӈ@eG81>RYwJ 9Ek/䇻4}zv$9x;Ho\ߏ$Q:7[HO?GWZOV4=YrD$̛ax t;tAY _n 󯺁̿jpәm'4P`@~ 90 s,|p3l )y 9}&DX9XGRjvaM'YGP }jE'0iH'I+? W~\򠅵 '+S< g<_xZ#σ/NfMtTY04 Rj'Y<YȣwyGD3sh!= E&N|,ԤP yJ`35n?lGPՋ{^5ͨ ^ NJs `G̚) 4(.,7%7Y@ ֝o!Js0@2a@yKW:G*@ g$yHV~|Jݏ( !oz$3E⺳zZ,`F|*h6@@ aO>ܟ!xXh0@,}*_iQ Ф$|>{K{ ~GKGQfƃPEՊg!zZVu?t)N| }j?Kl'C8}?*5o=ީנp]XhuΨK骵$HB U!@t9 }>N{k}Nnv}YKdUq'yRD%_߻QNR ´x崜F4\NF}m0@[[ )yTAS*p:jJ_~v~=\E u?'Wir«aI2VhN) ]]@/P pQekoJ07=h'n-SYUF'l6`\q$K_bNoK?˵ /_6>< P1 Kv5GOADyK yK 4http://crepsymar.apahp.frDyK olivier.bonnot@psl.aphp.fryK Dmailto:olivier.bonnot@psl.aphp.frSummaryInformation(DocumentSummaryInformation8CompObj'jotAP-HP3Microsoft Word 10.0@G@.J@Oaqy՜.+,D՜.+,p, hp  CHU de ToulouseI< 8Why should psychiatrists be interested in rare diseases Titre 8@ _PID_HLINKSALUg'"mailto:olivier.bonnot@psl.aphp.fr W$http://crepsymar.apahp.frXChttp://www.orphanet.org/  FDocument Microsoft Word MSWo@@@ tvNormalCJ_HaJmH sH tH :A@: Police par dfautViV Tableau Normal4 l4a 2k2 Aucune liste6@6 tvEn-tte  p#4)@4 tvNumro de pageBU@B tvLien hypertexte >*B*ph^C@"^ tvRetrait corps de texte$7$8$a$ 5CJ\@op=>QU%`%WWWXXXXcdepGԈfR1.00x0x0x0x0x0x000x0x0x0x0x0P0x0x0x0x0x0 00 0x0x00x000x0x0x0 0 000x0x00@00@00@00o@00o@0@0@0x@00|o >QU%`%W@0X @0@0@0@0X  j eB- <vQ_waړMPQRSTUVWXZ^_a͓NY`Od  |T#[#~&33499Z;HHuIUUWWWWZgg#hp;d}5fXQQQQQQQ:QQQXXw~!HnpqQ W ^#i# 4444.4:4<4I4gItIUUTX_XXXXXXXXXXXYY%Y,YYY]gfgggpg9AMR$)15;ڈ߈iptz $ y)*75;?FJQۍ;e}.56eg@npqde:A\]Ɉψ^dCKҊ݋#+V-.56eg3333333333333pWWe*i@ydefR@ddrddd[\ijuv`@`d`@`t`@``@`p@UnknownGz Times New Roman5Symbol3& z ArialG5  hMS Mincho-3 fg5& zaTahoma"1{&&qyIqyI$4<<:2qHX?tv7Why should psychiatrists be interested in rare diseasesCHU de ToulouseAP-HPrdDocWord.Document.89q